Hypercalcemia in a patient with SLE and antiphospholipid antibody syndrome: a rare case report from Bangladesh

Authors

  • G Dewan Consultant, Department oflnternal Medicine, Rangamati General Hospital, Rangamati

DOI:

https://doi.org/10.3126/jucms.v2i1.10490

Keywords:

Systemic lupus erythematosus (SLE), Hypercalcemia, Serositis, Lymphedema, Lymphadenopathy

Abstract

Association of hypercalcemia with SLE is very rare. Since initial report in 1991 only hand full cases have been described mainly in adult patients sporadically. Three pattern observed in this rare presentation. Commonly it is associated with serositis and lymphadenopathy or lymphedema known as hypercalcemia-lymphadenopathy SLE {HL-SLE) or hypercalcemia- lymphedema syndrome. Second group do not show this particular association. Concomitant primary hyperparathyroidism is responsible for third variety. This report describes a case of hypercalcemia associated with SLE from Bangladesh.

DOI: http://dx.doi.org/10.3126/jucms.v2i1.10490  

Journal of Universal College of Medical Sciences (2014) Vol.2(1): 35-37

Downloads

Download data is not yet available.
Abstract
773
PDF
545

Downloads

Published

2014-05-25

How to Cite

Dewan, G. (2014). Hypercalcemia in a patient with SLE and antiphospholipid antibody syndrome: a rare case report from Bangladesh. Journal of Universal College of Medical Sciences, 2(1), 35–37. https://doi.org/10.3126/jucms.v2i1.10490

Issue

Vol. 2 No. 1 (2014)

Section

Case Reports

License

Authors have to give the following undertakings along with their article:

  1. I/we declare that this article is original and has not been submitted to another journal for publication.
  2. I/we declare that I/we surrender all the rights to the editor of the journal and if published will be the property of the journal and we will not publish it anywhere else, in full or part, without the permission of the Chief Editor.
  3. Institutional ethical and research committee clearance certificate from the institution where work/research was done, is required to be submitted.
  4. Articles in the Journal are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)
  5. This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.